We are live on ! Find out more

1,970 hedge funds and large institutions have $146B invested in Pfizer in 2015 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 801 increasing their positions, 756 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 195 | Existing positions closed: 80

5% more funds holding

Funds holding: 1,8801,970 (+90)

1.41% more ownership

Funds ownership: 75.71%77.11% (+1.4%)

6% more repeat investments, than reductions

Existing positions increased: 801 | Existing positions reduced: 756

4% more capital invested

Capital invested by funds: $140B → $146B (+$6.18B)

5% less funds holding in top 10

Funds holding in top 10: 267253 (-14)

39% less call options, than puts

Call options by funds: $1.79B | Put options by funds: $2.95B

Holders
1,970
Holders Change
+90
Holders Change %
+4.79%
% of All Funds
51.67%
Holding in Top 10
253
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.24%
% of All Funds
6.64%
New
195
Increased
801
Reduced
756
Closed
80
Calls
$1.79B
Puts
$2.95B
Net Calls
-$1.16B
Net Calls Change
-$1.83B
Name Holding Trade Value Shares
Change
Change in
Stake
BFC
1201
Blue Fin Capital
Rhode Island
$1.6M +$35.6K +1,132 +2%
GC
1202
Grimes & Company
Massachusetts
$1.6M -$49.1K -1,562 -3%
CYG
1203
Clean Yield Group
Vermont
$1.59M -$4.97K -158 -0.3%
SAS
1204
Spectrum Advisory Services
Georgia
$1.59M -$6.67K -212 -0.4%
AP
1205
Appleton Partners
Massachusetts
$1.59M +$198K +6,308 +14%
JWM
1206
Jackson Wealth Management
Florida
$1.58M +$7.08K +225 +0.4%
PP
1207
Paloma Partners
Connecticut
$1.58M +$797K +25,336 +97%
SMC
1208
Smith, Moore & Co
Missouri
$1.58M +$946K +30,080 +140%
OC
1209
Oarsman Capital
Wisconsin
$1.57M -$57.9K -1,842 -3%
HIC
1210
Harvey Investment Company
Kentucky
$1.57M +$16.2K +515 +1%
CSS
1211
Cubist Systematic Strategies
Connecticut
$1.55M -$1.51M -48,002 -49%
LPT
1212
Legacy Private Trust
Wisconsin
$1.54M +$32K +1,016 +2%
SCM
1213
Sandler Capital Management
New York
$1.54M +$1.59M +50,418 New
CL
1214
Choreo LLC
Illinois
$1.54M -$26.4K -840 -2%
PIM
1215
Platinum Investment Management
Australia
$1.54M
DRS
1216
Deane Retirement Strategies
Louisiana
$1.53M -$29.4K -936 -2%
FCH
1217
Freestone Capital Holdings
Washington
$1.52M +$390K +12,387 +33%
PGIM
1218
Pacific Global Investment Management
California
$1.52M +$216K +6,878 +16%
FMC
1219
First Merchants Corp
Indiana
$1.51M +$118K +3,765 +8%
CHC
1220
City Holding Co
West Virginia
$1.51M -$2.45K -78 -0.2%
WEC
1221
Winslow Evans & Crocker
Massachusetts
$1.51M +$737K +23,431 +91%
WTB
1222
Washington Trust Bank
Washington
$1.51M +$14.2K +452 +0.9%
FC
1223
FIC Capital
New York
$1.51M +$17.7K +563 +1%
CIC
1224
Chilton Investment Company
Connecticut
$1.51M +$944K +30,001 +156%
RMCM
1225
Reynders McVeigh Capital Management
Massachusetts
$1.5M -$121K -3,837 -7%

PFE Hedge Fund Activity: Q4 2015 in Review

1,970 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2015, worth a combined $146B — up 4.4% from $140B a quarter earlier.

Buyers outnumbered sellers: 195 funds opened new PFE positions and 80 closed out — a net gain of 115 holders — while 801 added to existing stakes and 756 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $604M. The largest seller was Capital World Investors, cutting an estimated $1.47B.

  • 1,970 institutional investors held Pfizer (PFE) as of Q4 2015, up from 1,880 in Q3 2015.
  • Funds reported $146B of Pfizer stock for Q4 2015, up 4.4% quarter-over-quarter.
  • 195 funds opened new Pfizer positions in Q4 2015 and 80 closed out, a net change of +115 holders.
  • The largest Pfizer buyer in Q4 2015 was Deutsche Bank, an estimated $604M added.
  • The largest Pfizer seller in Q4 2015 was Capital World Investors, an estimated $1.47B sold.

Based on aggregated 13F filings for Q4 2015.